Participants in Joslin's Why WAIT (Weight Achievement and Intensive Management) program lost substantial amounts of weight, and even those who maintained relatively little loss of weight after five years demonstrated reduced risks of cardiovascular...
4-Jan-2017 2:05 PM EST Add to Favorites
People with any form of diabetes are at greater risk of developing cardiovascular conditions than people without the disease. Moreover, if they undergo an operation to open up a clogged artery by inserting a “stent” surgical tube, the artery is...
4-Jan-2017 1:05 PM EST Add to Favorites
Laurie J. Goodyear, PhD, at Joslin Diabetes Center will be part of the NIH's new MoTrPAC consortium and will help map molecular changes from physical activity.
14-Dec-2016 11:05 AM EST Add to Favorites
Most people struggle with their weight and are less active than ever before. Taken together, this toxic lifestyle can lead to serious health problems. The truth is that 86 million American adults—more than one out of three—have prediabetes....
11-Nov-2016 2:40 PM EST Add to Favorites
Joslin Diabetes Center investigators are shedding light on how the success of such microbiome treatments may be affected by genetics of the individual or animal being treated.
7-Nov-2016 2:05 PM EST Add to Favorites
Genes Influence Response to Glycemic Control as a Preventive Therapy for Cardiovascular Complications in Type 2 Diabetes
Genes play a role in how people with type 2 diabetes at high risk of cardiovascular disease risk respond to intensive glycemic control as an intervention to prevent the disease.
19-Sep-2016 12:05 PM EDT Add to Favorites
There are no established drugs to improve angiogenesis in diabetes. However, researchers at Joslin Diabetes Center now have identified a gene called CITED2 in a molecular pathway that may offer targets for drugs that treat these conditions by...
25-Aug-2016 2:05 PM EDT Add to Favorites
Researchers at Joslin Diabetes Center now have demonstrated that umbilical cells from children of obese or overweight mothers show impaired expression of key genes regulating cell energy and metabolism, compared to similar cells from babies of...
22-Aug-2016 3:05 PM EDT Add to Favorites
Dr. Lori Laffel, Chief of Pediatrics at Joslin Diabetes Center, Available to Comment on Type 1 Diabetes and Life Expectancy Studies
6-Jan-2015 11:00 AM EST
Lori Laffel, M.D., MPH, Chief of the Pediatric, Adolescent and Young Adult Section at Joslin Diabetes Center and Associate Professor of Pediatrics at Harvard Medical School, oversees the largest pediatric diabetes clinic in New England has over 25...
15-Aug-2014 8:00 AM EDT
13-Nov-2013 1:00 PM EST
The International Diabetes Federation now recommends that surgery be considered as a treatment for obese patients with type 2 diabetes. Dr. Allison Goldfine, head of clinical research at Joslin Diabetes Center, is available for comment.
29-Mar-2011 9:00 AM EDT
Emerging technologies such as continuous glucose monitoring (CGM) are helping people with type 1 diabetes manage their condition—what are the next steps? Howard Wolpert, M.D., of Joslin Diabetes Center discusses his current research and the global...
1-Oct-2010 1:00 PM EDT